Never miss an important article again, stay on top of your investments and become a better investor today! Get your moat on and sync your watchlist with Stocktwits to get all the latest news for your symbols.
Sync with StocktwitsCompany Name : |
Achieve Life Sciences |
Exchange : |
NASDAQ |
Industry : |
In-Vitro Diagnostic Substance Manufacturing |
Sector : |
Manufacturing |
Employees : |
13 |
Headquarters: |
Seattle - US |
Website: |
achievelifesciences.com |
Description : Tobacco use is currently the leading cause of preventable death that is responsible for more than eight million deaths worldwide. and nearly half a million deaths in the U.S. annually.12 More than 87% of lung cancer deaths, 61% of all pulmonary disease deaths, and 32% of all deaths from coronary heart disease are attributable to smoking and exposure to secondhand smoke. Achieve s focus is to address the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline. Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is believed to aid in smoking cessation by interacting with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms and by reducing the reward and satisfaction associated with smoking.
Achieve Life Sciences (ACHV)
